Table 3.

RR (95% CI) of pancreatic cancer according to available clinical measurements

CasesRR (95% CI)
Adjusted*Adjusted
Total cholesterol (mg/dL)
    <2001,2321.01.0
    200-2396470.91 (0.83-1.01)0.91 (0.82-1.00)
    240+3111.00 (0.88-1.13)0.97 (0.85-1.10)
Ptrend0.980.77
SBP (mm Hg)
    <1205301.01.0
    120-1294870.97 (0.86-1.10)0.97 (0.86-1.10)
    130-1394671.01 (0.89-1.14)1.01 (0.89-1.14)
    140+7100.99 (0.88-1.11)0.98 (0.88-1.10)
Ptrend0.910.98
WBC (cells/L)
    1st2261.01.0
    2nd2521.07 (0.92-1.24)1.08 (0.93-1.26)
    3rd2130.97 (0.83-1.14)0.98 (0.83-1.14)
    4th2651.12 (0.97-1.30)1.11 (0.96-1.29)
    5th2621.08 (0.93-1.26)1.05 (0.91-1.22)
Ptrend0.330.58
AST
    <205781.01.0
    20-309760.99 (0.89-1.10)1.00 (0.90-1.11)
    30-404121.18 (1.04-1.34)1.19 (1.05-1.35)
    40+2241.34 (1.15-1.56)1.33 (1.14-1.55)
Ptrend0.060.05
ALT
    <209751.01.0
    20-307081.05 (0.96-1.16)1.06 (0.96-1.16)
    30-402731.19 (1.04-1.36)1.19 (1.04-1.36)
    40+2341.36 (1.18-1.57)1.34 (1.16-1.56)
Ptrend0.020.02
  • * Adjusted for age and gender.

  • Adjusted for age, gender, body mass index, smoking, and fasting serum glucose levels.

  • Sex-specific quintiles WBC: male (<5,700, 5,700-6,599, 6,600-7,399, 7,400-8,499, and ≥8,500) and female (<5,200, 5,200-5,999, 6,000-6,699, 6,700-7,699, and ≥7,700).